Trial Profile
A double-blind and placebo-controlled study of omadacycline assessing pharmacokinetic (PK) in healthy volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 May 2016
Price :
$35
*
At a glance
- Drugs Omadacycline (Primary)
- Indications Community-acquired pneumonia; Skin and soft tissue infections
- Focus Pharmacokinetics
- 18 May 2016 New trial record
- 12 Apr 2016 Results of this and other trial (see profile 271391) assessing an effect of age and gender on the pharmacokinetics presented at the 26th European Congress of Clinical Microbiology and Infectious Diseases